For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Deutsche Bank AG (DB) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Bounce · Gem Score +8 (−100…+100 Quality+Value blend) · Quality -7 · Value 21 · Sentiment 16 (timing only, not weighted)
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Deutsche Bank AG
DB NYSEDeutsche Bank AG is a global financial services institution and one of the leading banks in Germany. Headquartered in Frankfurt am Main, it serves corporate, institutional, and private clients through its core businesses: Corporate Bank, Investment Bank, Private Bank, and Asset Management. The bank provides transaction banking, lending, treasury services, foreign exchange, capital markets access, advisory solutions, and wealth management, supporting companies, governments, and individual clients across major international markets. Deutsche Bank AG also plays a significant role in European banking by combining commercial and investment banking capabilities with a broad global network. Its asset management activities add another layer to its market presence, making it an important provider of banking, financing, and investment services across multiple sectors.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
Deutsche Bank AG is a foreign private issuer — it reports to the U.S. SEC once a year (on Form 20-F or 40-F) rather than filing the quarterly statements (10-Q) that U.S.-domiciled companies must submit. Our financial statements are read directly from SEC filings, so for this company only annual figures exist at the source.
This is a property of how the company files, not missing or broken data — its filing history shows 9 annual reports, the latest filed 2026-03-12, and no quarterly filings . The company may still publish quarterly results on its own investor-relations site.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 3.57
Total Equity: $94.98B
Shares: 2,243,042,071
Total Debt: $0.00
Cash: $0.00
EBITDA: N/A
Total Debt: $0.00
Cash: $0.00
Revenue: $36.28B
Revenue: $36.28B
Revenue: $36.28B
Total Equity: $94.98B
Tax Rate: 26.6%
Equity: $94.98B
Total Debt: $0.00
Cash: $0.00
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $94.98B
Shares: 2,243,042,071
Shares: 2,243,042,071
CapEx: -$487.09M
Shares: 2,243,042,071
Stock Price: $38.30
Net Income: $8.00B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 11, 2026 12:28pm (12d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $29.5B | $31.2B | $36.0B | $36.4B | $36.3B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $12.5B | $11.2B | $11.7B | $13.0B | $10.2B |
| Operating Income | — | — | — | — | — |
| Net Income | $2.8B | $6.3B | $7.3B | $4.7B | $8.0B |
| EBITDA | — | — | — | — | — |
| EPS | $1.11 | $2.79 | $2.39 | $1.62 | $3.65 |
| EPS (Diluted) | $1.07 | $2.74 | $2.34 | $1.58 | $3.57 |
Balance Sheet (Annual)
Last updated: Aug 11, 2026 12:28pm (12d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $207.7B | $191.2B | $189.0B | — | — |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $1.5T | $1.6T | $1.5T | $1.6T | $1.7T |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $1.5T | $1.5T | $1.4T | $1.5T | $1.6T |
| Total Equity | $78.6B | $83.3B | $88.1B | $94.5B | $95.0B |
| Retained Earnings | $14.6B | $20.5B | $26.4B | — | — |
Cash Flow (Annual)
Last updated: Aug 11, 2026 12:28pm (12d ago)| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$46.7B | $35.5B | -$3.4B | -$2.4B | $6.5B |
| Capital Expenditure | $377.4M | $591.0M | $634.8M | $389.0M | -$487.1M |
| Free Cash Flow | -$46.3B | $36.1B | -$2.8B | -$2.0B | $6.0B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | $262.0M | $0 | $0 | $468.6M | -$704.1M |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | -$60.0B | $31.7B | $27.3B | -$16.5B | -$2.1B |
Growth Trends (YoY %)
Last updated: Aug 11, 2026 12:28pm (12d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +6.0% | +15.1% | +1.1% | -0.2% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | +121.1% | +16.8% | -36.3% | +72.0% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 11, 2026 12:28pm (12d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-29 | $1.17 | — | — | — |
| 2025-05-23 | $0.77 | — | — | — |
| 2024-05-17 | $0.49 | — | — | — |
| 2023-05-18 | $0.33 | — | — | — |
| 2022-05-20 | $0.21 | — | — | — |
| 2019-05-24 | $0.12 | — | — | — |
| 2018-05-25 | $0.13 | — | — | — |
| 2017-05-19 | $0.21 | — | — | — |
| 2015-05-22 | $0.74 | — | — | — |
| 2014-05-23 | $0.83 | — | — | — |
| 2013-05-24 | $0.79 | — | — | — |
| 2012-06-01 | $0.79 | — | — | — |
| 2011-05-27 | $0.87 | — | — | — |
| 2010-05-28 | $0.56 | — | — | — |
| 2009-05-27 | $0.37 | — | — | — |
| 2008-05-30 | $3.34 | — | — | — |
| 2007-05-25 | $5.13 | — | — | — |
| 2004-06-03 | $1.75 | — | — | — |
| 2003-06-11 | $1.15 | — | — | — |
| 2002-05-23 | $1.15 | — | — | — |
Deep Analysis
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-11DB's problem has always been cost, not demand: an oversized run-rate in KYC/AML, regulatory reporting, controls, client onboarding and IT support is precisely the work generative models compress, and every point of cost/income improvement drops straight to a bank earning ~$8B on ~$36B of revenue.
German co-determination, works councils and multi-jurisdiction regulatory approval make headcount reduction slow and expensive, so AI productivity may show up as flat costs plus higher tech spend rather than falling costs — while US megabanks with 3-4x the technology budget widen an absolute AI capability gap DB cannot outspend.
Whether AI savings actually land in the cost/income ratio versus being absorbed by severance, restructuring charges and a rising tech-spend floor; the observable is adjusted cost/income and absolute noninterest expense trending down for four-plus consecutive quarters while IT investment rises.
A German/EU banking licence with full capital permissions, the corporate transaction-banking and correspondent payment network, custody mandates, and decades of embedded Mittelstand and institutional relationships — none of which cheap software creates.
AI Lens thesis
The customer needs DB serves — credit, payments, custody, market access, wealth stewardship, balance-sheet risk-taking — are untouched by intelligence getting cheap; what changes is the labor intensity of delivering them and the price transparency around execution. DB is unusually leveraged to the cost channel because its historic weakness is a heavy, fragmented operating platform, so honest AI adoption is worth more to DB than to an already-efficient peer. Against that: a fragmented legacy data estate is the binding constraint on deploying AI at scale, European labor law delays realization, agentic price-shopping erodes FX and execution spreads at the margin, and DWS faces continued active-fee compression. Meanwhile the AI capex cycle is a demand tailwind — data-center and infrastructure financing, DCM/M&A fees, and AI-driven volatility supporting FIC volumes. Net: a modest structural positive whose size depends entirely on execution, not on technology.
What the market may be underestimating
Upside DB is a lender and capital-markets arranger to Europe's AI and data-center buildout — an underpriced volume tailwind in loan growth, project finance and DCM fees that is AI-driven demand rather than AI-driven cost.
Downside AI raises the minimum viable technology spend for a global bank; DB's absolute budget disadvantage versus JPMorgan-scale rivals means it can lose institutional share in electronic execution and prime services even while cutting costs, extending the share-loss gap already visible versus industry growth.
Outcome range spread 39
Claude Reading
Looking at the raw numbers first: revenue has been essentially flat for three years ($35.96B → $36.36B → $36.28B), a 0.5% CAGR that would embarrass a utility. The 72% earnings YoY jump to $8.00B is the entire story here — and it's suspicious. NI swung from $2.83B (2021) to $6.26B (2022) to $7.31B (2023) to $4.65B (2024) to $8.00B (2025). That's not a trajectory, it's noise. For a bank, this kind of volatility screams provision releases, litigation reversals, DTA revaluations, or one-off items — not durable operating leverage. At 8.4% ROE, DB is still not earning its cost of equity (call it 10-11% for a European universal bank), which is exactly why the market is paying 0.9x book. That's not mispricing; that's arithmetic.
Now the model stack. The synthesis says "fair value" with a composite of $50.63 signal-adjusted to $43.95 — a 15% upside — while flagging poor cash flow quality. Market Forces calls it a value trap. Thesis Evaluation scores -7 and points out the DCF requires implicit FCF quintupling that has no precedent. These are not compatible views dressed up as nuance; they're contradictory, and the DCF-derived fair value is the weak link. A DCF on a bank is already borderline malpractice (banks don't have meaningful FCF in the industrial sense — the $5.98B OCF from 2023 is a working-capital artifact of a balance sheet business), and extrapolating from a lumpy earnings base compounds the error. The pre-flight "deep value" framing and the narrative layer's "fallen angel/anchored" read are the more honest calls. P/B of 0.9x on 8.4% ROE is roughly fair — the Gordon growth identity (P/B = (ROE-g)/(r-g)) with ROE 8.4%, r 10%, g 2% gives P/B ≈ 0.8x. So DB is trading almost exactly where a sober regional-comp model would put it.
The contrarian bull case is real but narrow: if DB can push ROE to 10-11% sustainably (management's target), fair P/B moves to 1.0-1.1x, implying $42-47/share — modest upside from $38.30, not a double. The contrarian bear case is that ECB is cutting, NII will compress, the IB revenue is cyclically peaked, and the 2025 $8B print includes non-recurring items that won't repeat in 2026 — so normalized EPS is closer to the $4.65B 2024 figure, putting real P/E closer to 15x, not 10.7x. Insider activity isn't shown, and the balance sheet detail (total debt "—", cash "—") is missing for a *bank*, which is the entire business. That's a data gap the models glossed over. The 2023-dated cash flow statement in a 2025 review is stale by two years in a rate-cut regime.
My verdict: I dissent partially from the "fair value with 15% upside" synthesis and side closer to Market Forces and Thesis Evaluation. The composite DCF is overstating fair value because it's applying industrial-company FCF logic to a bank whose earnings just had a suspicious 72% YoY jump on flat revenue. Fair value is $38-42 — essentially where it trades. This is not a $50 stock. The 2.6% dividend and low P/B provide a floor, but there's no growth engine, ROE remains sub-cost-of-capital, and the 2025 earnings surge is unlikely to be the new run-rate. It's not a short (too cheap on book, too much capital return optionality) but it's not the 15% upside opportunity the synthesis implies. A patient value investor collecting the dividend while waiting for ROE to prove itself makes sense; anyone underwriting the composite fair value is buying a DCF hallucination.
GPT Reading
The core fact here is that Deutsche Bank is no longer a distressed restructuring story, but it also is not yet earning enough to deserve a premium valuation. Revenue has risen from $29.48B in 2021 to $36.28B in 2025, but almost all of that progress came by 2023; since then the top line has flattened at $35.96B, $36.36B, and $36.28B. That matters because banks can mask mediocre franchise growth with cycle-driven profitability for a while. Net income looks strong at first glance — $8.00B in 2025 versus $2.83B in 2021 — yet the path is uneven: $6.26B in 2022, $7.31B in 2023, then a drop to $4.65B in 2024 before the rebound. That is not the profile of a clean compounding franchise; it is the profile of a bank still exposed to capital-markets volatility, rate sensitivity, and one-off noise. At $71.9B market cap, the market is valuing the company at about 0.90x book on $94.98B equity and 10.7x earnings. For a bank producing just 8.4% ROE, that is about right: below book because returns are still below what I’d consider a full cost-of-equity clearing level.
What stands out most is the tension between reported earnings and the franchise’s actual growth engine. Net margin of 22.1% sounds excellent, but ROA is only 0.48%, which is fairly ordinary for a large regulated bank and a reminder that balance-sheet-heavy earnings do not equal exceptional economics. If I take 2025 net income of $8.00B on $94.98B equity, I get roughly the same mid-8% return profile as the reported ROE. That is respectable, not rerating-worthy. A bank trading near book generally needs a believable path to sustained 10%-12% ROE, not a single good earnings year. The revenue CAGR cited at just 0.5% reinforces that this is largely a self-help and efficiency story, not a growth story. For that reason I do not buy the more bearish machine narrative that the stock is pricing heroic expansion; a 0.9x P/B and 10.7x P/E do not scream euphoric expectations. If anything, the market is saying: prove this level of earnings is durable and maybe you can trade at book or slightly above.
The biggest contradiction in the data is the “poor cash flow quality” warning being treated as if it carries the same meaning as in an industrial company. For banks, operating cash flow and free cash flow are notoriously noisy and often not decision-useful in the conventional sense, because working capital, deposits, trading assets, and regulatory movements swamp the signal. Using 2023 operating cash flow of $6.47B and free cash flow of $5.98B as a hard anchor for valuation is shaky, and extrapolating to claims that the market expects $30B of future FCF feels detached from how bank equities actually trade. Deutsche Bank should be judged primarily on capital, profitability, and stability of earnings. On those metrics, it looks improved but not transformed. A sub-book multiple is therefore deserved, but the discount should be modest rather than punitive. I can justify something around 0.95x-1.0x book if management can hold earnings around $7B-$8B; that implies equity value of roughly $90B-$95B, or around 25%-30% above the current market cap, before adjusting for execution risk. So there is value here, but it is the dull kind: a re-rating candidate, not a runaway compounder.
The best bear case is straightforward and credible. First, revenue is stalling: $36.36B to $36.28B in the latest year is effectively no growth, so the 2025 earnings rebound may prove more cyclical than structural. Second, 8.4% ROE is still below the level that would merit a premium to book, especially for a European bank with a long history of strategic resets and reputational baggage. Third, the 2024 profit dip to $4.65B shows that earnings power is less stable than the 2025 snapshot suggests. Fourth, if ECB rate cuts compress margins and investment-banking conditions soften, the bank may struggle to keep net income above $6B, in which case even 0.9x book is not obviously cheap. Those are real issues, and they are why I do not view this as deeply undervalued. I weigh them differently because the current valuation already reflects a lot of that skepticism; this is not a bank on 1.4x book priced for perfection, but one still treated as if mediocre returns are its ceiling.
What would change my mind is pretty specific. If the next set of annual numbers show revenue still stuck around $36B but net income falling back toward $5B and ROE slipping below 7%, I’d move bearish quickly because that would confirm 2025 was a high-water mark, not a new base. I’d also turn more negative if tangible capital weakens or the bank cannot defend book value through the cycle. On the other hand, if Deutsche can deliver two consecutive years of roughly $7.5B-$8.5B net income with revenue at least stable and push ROE into the 10% area without balance-sheet games, the stock should trade at or above book, which would support a price closer to the low-to-mid $40s and potentially higher depending on capital return.
Grok Reading
The raw numbers describe a bank that has stopped shrinking but has not started growing. Revenue has been effectively frozen near $36B for three consecutive years ($35.96B → $36.36B → $36.28B), producing a five-year CAGR of just 0.5%. Against that stasis, net income has thrashed around: $2.83B, $6.26B, $7.31B, $4.65B, then a jump to $8.00B. The latest 72% earnings surge on a −0.2% revenue print is the clearest signal in the dataset—it cannot be operating leverage from the franchise; it is mix, provisions, markets income, or one-offs. A 22% net margin is not a European universal bank’s sustainable run-rate; multi-year average earnings power sits nearer $5.5–6.5B than the $8B headline. At $38.3 and a $72B market cap, the stock therefore trades at roughly 11× trailing reported earnings but closer to 12–13× normalized, and at 0.90× tangible book of ~$95B. ROE of 8.4% and ROA of 0.48% confirm the franchise still earns below a sensible European cost of equity through the cycle. That is the entire valuation story: a modest discount to book for a bank that has stabilized capital and litigation overhang but has not demonstrated durable double-digit returns or a revenue engine.
The prior models disagree with each other in instructive ways. The deep-value framing and 0.9× book correctly capture residual skepticism, and the composite fair-value path around $44 implies only mid-teens upside—hardly a distressed mispricing. Where the briefing overreaches is the claim that the market is embedding a quintupling of FCF to ~$30B. A stock at sub-book with mid-single-digit revenue drift and 8% ROE is pricing mediocrity and execution risk, not a heroic cash-flow compound. The “value trap / avoid” market-forces call is directionally useful on earnings quality (the FCF quality flag and the 2023 OCF/FCF of $6.5B/$6.0B against lumpy NI are real), but it overstates structural doom relative to the simple arithmetic that 0.9× book for an 8%-ROE bank with a 2.6% dividend is close to fair if ROE merely holds. The fallen-angel narrative layer is the right register: moderate intensity, low cult, “show me” recovery—not a bubble and not a zombie.
The strongest case against a constructive lean is straightforward. Revenue has no visible growth vector while ECB easing threatens NIM; the Investment Bank’s contribution is cyclical and still competes at a disadvantage to US bulge brackets; European regulatory and capital drag is permanent; and the $8B NI year is an unreliable anchor. If normalized earnings are $5.5B, the multiple is no longer cheap, ROE stays sub-COE, and the stock is a classic value trap that can grind sideways for years at 0.8–1.0× book. That bear case deserves real weight—my mild undervaluation call rests on the judgment that capital release, cost discipline, and the absence of fresh litigation shocks can keep ROE in the 8–10% band and support a gradual re-rating toward 1.0× book, not on any assumption of a new growth regime.
I would flip to a clear avoid if the next two printings show NI falling back below $5.5B without an obvious non-repeatable item, or if revenue breaks meaningfully below $34B as rates compress. I would flip to a higher-conviction long if management delivers two consecutive years of ROE ≥10% with revenue at least flat-to-up and clean FCF conversion above $7B, which would justify a move through $45–48 toward book value.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Deutsche Bank's top line has stabilized in the mid-$36B range (2023 $35.96B, 2024 $36.36B, 2025 $36.28B), and net income has recovered materially from $2.83B in 2021 to $8.00B in 2025. Diluted share count has trended down (-3.1% CAGR, 2.94B in 2024 to 2.24B in 2025 suggests meaningful buyback/cancellation activity), which is a genuine positive for per-share value in a sector that historically dilutes. FCF is highly volatile as is normal for a bank (loan-book and trading-asset swings dominate operating cash flow): $-46.3B, $+36.1B, $-2.8B, $-2.0B, $+6.0B. The five-year sum is negative, and OCF/NI of -2.2x in the latest print underscores that reported earnings are not being backed by clean operating cash, though for a universal bank this reflects balance-sheet mechanics more than accrual manipulation.
Verify before trusting this (6)
- CET1 ratio and leverage ratio trend versus regulatory minima
- Composition of the 2021 $-46.3B and 2022 $+36.1B FCF swings - trading assets vs. loan book vs. deposits
- Whether the drop in diluted shares from 2.94B (2024) to 2.24B (2025) reflects actual buyback/cancellation or a data artifact
- Sustainability of Investment Bank revenue mix versus stable Corporate/Private Bank fee income
- Provision for credit losses trend and NPL ratios
- Ongoing litigation and regulatory reserves
The e2e composite pegs fair value at $50.63 with a signal-adjusted $43.95, implying roughly 15% upside from $38.27. Anchored-PE lands at the same $50.63, so the methods are internally consistent rather than a single runaway model. Netting the earnings-quality haircut (weak FCF conversion, erratic cash generation typical of a large universal bank) I lean on the lower $43.95 anchor as the more honest deserved price. That still leaves a ~15% gap - meaningful, but not a screaming discount.
Verify before trusting this (5)
- Sustainability of the IB profitability recovery in the next 2 quarters
- Cash conversion trend - is FCF finally turning consistently positive
- CET1 trajectory and any signal on buyback pace
- Litigation/legacy provisions - any fresh disclosures
- Guidance on cost/income ratio target progress
The macro tape is modestly risk-on (VIX 15.5, S&P near highs, JPM raising targets on AI-driven earnings), which is a gentle tailwind for cyclicals and financials broadly. But DB is a low-beta (0.99), European universal bank, so the AI-euphoria leg of the rally does not really land on this name; the pressure it feels is more from the general 'buy cyclicals into a calm tape' bid than from any story it owns. Higher 10y at 4.65% is a mild ambient headwind for equities but arguably helps a bank's NIM narrative at the margin. The active narrative is fallen-angel with moderate intensity and low cult - the market is neither punishing nor celebrating DB. The bull story (stabilization, IB profitability, receding litigation) is grinding higher slowly; the bear story (structurally challenged EU bank, zombie persistence) is dormant but not dead. Nothing is running ahead of fundamentals here. News flow is quietly positive: the China renminbi clearing designation is a genuine franchise-credential headline that fits the 'rehabilitation' arc, and DB showing up as an underwriter/backer of the SpaceX revenue thesis is subtle IB-relevance signal. Neither is a tape-moving catalyst, but both nudge the narrative the right way with no offsetting bad news in the window.
Verify before trusting this (4)
- Any crack in EU credit conditions or Bund-spread widening that would reignite the zombie-bank narrative
- US bank earnings revisions and whether the rehabilitation read-across extends to EU peers
- Analyst target revisions on DB and Street tone shifts around the IB franchise
- ECB policy path and 10y bund moves that would swing NIM sentiment
The customer needs DB serves — credit, payments, custody, market access, wealth stewardship, balance-sheet risk-taking — are untouched by intelligence getting cheap; what changes is the labor intensity of delivering them and the price transparency around execution. DB is unusually leveraged to the cost channel because its historic weakness is a heavy, fragmented operating platform, so honest AI adoption is worth more to DB than to an already-efficient peer. Against that: a fragmented legacy data estate is the binding constraint on deploying AI at scale, European labor law delays realization, agentic price-shopping erodes FX and execution spreads at the margin, and DWS faces continued active-fee compression. Meanwhile the AI capex cycle is a demand tailwind — data-center and infrastructure financing, DCM/M&A fees, and AI-driven volatility supporting FIC volumes. Net: a modest structural positive whose size depends entirely on execution, not on technology.
None surfaced.
Verify before trusting this (8)
- Adjusted cost/income ratio trajectory
- Absolute noninterest expense trend
- Headcount and restructuring charges
- Corporate Bank transaction volumes
- Loan book growth vs eurozone GDP
- Institutional custody mandate wins
- Regulatory findings and remediation costs
- Litigation provision trend
This lens hasn't been run for this ticker yet.
Prediction unavailable. valuation-synthesis has no result for DB — the prediction needs its fair-value anchors.